Head-to-Head Comparison

BPC-157 vs TB-500

Two of the most popular healing peptides in research. One works locally, the other systemically. Here’s how they compare and when to use each.

	BPC-157	TB-500
Full Name	Body Protection Compound-157	Thymosin Beta-4 Fragment
Class	Gastric Peptide	TB4 Fragment
Origin	Derived from human gastric juice	Synthetic fragment of Thymosin Beta-4
Reach	Localized – works near injection site	Systemic – distributes throughout body
Route	SubQ or Oral	SubQ or IM only
Half-Life	~4 hours	~14 days
Dose Range	250–500 mcg	2–2.5 mg
Frequency	1–2x daily	2x weekly (loading), 1x weekly (maintenance)
Cycle Length	4–12 weeks	8–14 weeks (loading + maintenance)
Primary Use	Tendon, gut, and localized tissue repair	Systemic muscle, connective tissue repair
Mechanism	Angiogenesis, growth factor modulation, NO system	Actin regulation, cell migration, anti-inflammatory
Oral Option	Yes – stable in gastric acid	No – degraded in GI tract
Cost (per vial)	$64.99 (10 mg)	$19.99 (2 mg)

When to Use Each

Choose BPC-157 When

You have a specific localized injury (tendon, joint, muscle)
Gut healing is the primary goal (IBS, leaky gut, ulcers)
You prefer oral administration over injections
The injury site is accessible for localized SubQ injection
You want a shorter, simpler dosing protocol
Post-surgical recovery at a specific site

Choose TB-500 When

You have multiple injury sites or widespread inflammation
The injury is hard to reach with localized injection
Muscle or connective tissue damage is the primary concern
You want less frequent dosing (2x weekly vs daily)
Cardiac or dermal wound healing is the research focus
Systemic anti-inflammatory effect is the goal

Better Together: The Healing Stack

BPC-157 and TB-500 are one of the most popular peptide stacks in research because they work through completely different mechanisms that complement each other.

BPC-157 handles the local work – angiogenesis at the injury site, growth factor upregulation, and direct tissue repair where you inject it.

TB-500 handles the systemic work – whole-body anti-inflammatory signaling, actin regulation, and cell migration to every damaged area regardless of injection site.

Together, they provide both targeted and systemic healing coverage. A typical combined protocol runs BPC-157 at 250–500 mcg daily (SubQ near the injury) alongside TB-500 at 2–2.5 mg twice weekly for 4–6 weeks.

View the Full Healing Stack Protocol

Detailed dosing schedule, cycle timing, and reconstitution guide for the BPC-157 + TB-500 combination.

View Healing Stack →

Read the Full Guides

BPC-157

Mechanisms, dosing protocols, FAQ, and sourcing.

Full BPC-157 Guide →

TB-500

Mechanisms, dosing protocols, FAQ, and sourcing.

Full TB-500 Guide →

Disclaimer: This content is provided for educational and informational purposes only. BPC-157 and TB-500 are sold as research compounds and are not intended for human consumption. Always consult a licensed healthcare provider before using any peptide or research compound. PeptideSet.com does not sell peptides directly. Product listings reference third-party suppliers for comparison purposes.